
Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …

Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …

